TNB
REGN icon

TCF National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

TCF National Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$456K Buy
964
+170
+21% +$82.8K 0.05% 274
2020
Q4 		$384K Buy
794
+233
+42% +$126K 0.04% 288
2020
Q3 		$314K Buy
+561
New +$340K 0.04% 293

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCF National Bank's REGN Position: Q1 2021 in Review

TCF National Bank increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q1 2021, buying an estimated $82.8K and bringing the position to 964 shares worth $456K. The position accounts for 0.05% of the portfolio, ranked #274.

TCF National Bank first reported a position in REGN in Q3 2020 and has held it in 3 quarters since. 924 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

  • TCF National Bank held 964 shares of Regeneron Pharmaceuticals worth $456K as of Q1 2021.
  • TCF National Bank bought 170 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $82.8K.
  • Regeneron Pharmaceuticals made up 0.05% of TCF National Bank's portfolio in Q1 2021, its #274 holding.
  • TCF National Bank first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 3 quarters since.
  • 924 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.